Skip to content
Friday 14 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 15 February 2022 1:46 pm

Extremely deadly Ebola virus can hide in survivor’s brain for five years after treatment and recovery

By: Michiel Willems

Add as a preferred source on Google
Ebola strain

The extremely lethal virus Ebola is able to ‘hide’ in the brain for years despite treatment and recovery, according to new research.

US researchers found that monkeys that survived an Ebola infection still carried the virus years later in their brains.

“We have found that about 20 per cent of monkeys that survived a lethal dose of the Ebola virus after treatment with monoclonal antibodies still had a persistent infection, particularly in the ventricular system of the brain, where cerebrospinal fluid is produced and circulates – and even after Ebola had been removed from other organs,” according to Xiankun Zen, principal investigator of the study published in Science Translational Medicine.

Zen stressed that the case of two monkeys was particularly disturbing: the animals survived the initial infection but eventually died due to a resurgence of the virus years later, unexpectedly.

Zen and his team call this ‘long Ebola’, or “the persistent presence of the Ebola virus in the brain caused the death of ependymocytes – a family of cells that are part of the blood-brain barrier in the choroid plexus,” according to a Gilmore Health report.

“Severe local inflammation occurred and the virus spread to the ventricular system of the brain, causing the animals to die.”

“The Ebola virus has also been shown previously to also hide in humans.”

Gilmore Health report

Last year, researchers analysed the case of a man in whom the virus remained latent for five years in his testicles.

The man reportedly went on to infect a woman in Guinea, causing an outbreak in the local district where the two were residing.

Ebola vaccines and treatments can contain outbreaks, but researchers warn that long-term monitoring of survivors is needed to prevent outbreaks, Gilmore Health said.

Ebola is one of the deadliest human viruses known to man, and more than half of those infected succumb to the disease.

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Morning Wire Content

Related Topics

  • Ebola

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • It’s not just Jason Arday, most of sociology is a scam

  • Revolut chatbot goes rogue by charging users to cancel subscription

More from Morning Wire

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

    Business Wire
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
  • VoxNeuro Receives FDA 510(k) Clearance for Cognitive Function Neuroimaging (cfNI) Software – An Objective EEG/ERP Brain Health Assessment

    Business Wire
  • Manchester United accused of banning loyal fans to make space for big-spending tourists

    Sport Business
    Excited football fans in a stadium, many wearing red shirts, cheering and holding up phones.
  • Wimbledon: HMRC set to slap Sinner and Noskova with £1.6m tax bill

    Sport Business
    Getty Images logo on a sleek black background, symbolizing reliable sources for high-quality stock photography and media c...
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook